Literature DB >> 30892117

Interferon Lambda: An Immune System Factor That Cancer Epidemiologists Should Consider.

Danielle Mercatante Carrick1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30892117      PMCID： PMC6767861          DOI： 10.1089/jir.2019.0033

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN： 1079-9907            Impact factor:   2.607


× No keyword cloud information.
  11 in total

Review 1.  Type III Interferons in Antiviral Defenses at Barrier Surfaces.

Authors:  Alexandra I Wells; Carolyn B Coyne
Journal:  Trends Immunol       Date:  2018-09-12       Impact factor: 16.687

2.  Type III IFNs Are Commonly Induced by Bacteria-Sensing TLRs and Reinforce Epithelial Barriers during Infection.

Authors:  Charlotte Odendall; Andrew A Voak; Jonathan C Kagan
Journal:  J Immunol       Date:  2017-09-27       Impact factor: 5.422

3.  A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus.

Authors:  Ludmila Prokunina-Olsson; Brian Muchmore; Wei Tang; Ruth M Pfeiffer; Heiyoung Park; Harold Dickensheets; Dianna Hergott; Patricia Porter-Gill; Adam Mumy; Indu Kohaar; Sabrina Chen; Nathan Brand; McAnthony Tarway; Luyang Liu; Faruk Sheikh; Jacquie Astemborski; Herbert L Bonkovsky; Brian R Edlin; Charles D Howell; Timothy R Morgan; David L Thomas; Barbara Rehermann; Raymond P Donnelly; Thomas R O'Brien
Journal:  Nat Genet       Date:  2013-01-06       Impact factor: 38.330

Review 4.  Interferon-λ: Immune Functions at Barrier Surfaces and Beyond.

Authors:  Helen M Lazear; Timothy J Nice; Michael S Diamond
Journal:  Immunity       Date:  2015-07-21       Impact factor: 31.745

5.  Genome-wide significant risk associations for mucinous ovarian carcinoma.

Authors:  Linda E Kelemen; Kate Lawrenson; Jonathan Tyrer; Qiyuan Li; Janet M Lee; Ji-Heui Seo; Catherine M Phelan; Jonathan Beesley; Xiaoqing Chen; Tassja J Spindler; Katja K H Aben; Hoda Anton-Culver; Natalia Antonenkova
Journal:  Nat Genet       Date:  2015-06-15       Impact factor: 38.330

Review 6.  Interferon (IFN)-λ Takes the Helm: Immunomodulatory Roles of Type III IFNs.

Authors:  Ivan Zanoni; Francesca Granucci; Achille Broggi
Journal:  Front Immunol       Date:  2017-11-28       Impact factor: 7.561

Review 7.  Interferon-λs: Front-Line Guardians of Immunity and Homeostasis in the Respiratory Tract.

Authors:  Evangelos Andreakos; Maria Salagianni; Ioanna E Galani; Ourania Koltsida
Journal:  Front Immunol       Date:  2017-09-29       Impact factor: 7.561

Review 8.  Interferon-Lambda: A Potent Regulator of Intestinal Viral Infections.

Authors:  Sanghyun Lee; Megan T Baldridge
Journal:  Front Immunol       Date:  2017-06-30       Impact factor: 7.561

9.  Genome-to-genome analysis highlights the effect of the human innate and adaptive immune systems on the hepatitis C virus.

Authors:  M Azim Ansari; Vincent Pedergnana; Camilla L C Ip; Andrea Magri; Annette Von Delft; David Bonsall; Nimisha Chaturvedi; Istvan Bartha; David Smith; George Nicholson; Gilean McVean; Amy Trebes; Paolo Piazza; Jacques Fellay; Graham Cooke; Graham R Foster; Emma Hudson; John McLauchlan; Peter Simmonds; Rory Bowden; Paul Klenerman; Eleanor Barnes; Chris C A Spencer
Journal:  Nat Genet       Date:  2017-04-10       Impact factor: 41.307

10.  IFNL4-ΔG is associated with prostate cancer among men at increased risk of sexually transmitted infections.

Authors:  Tsion Zewdu Minas; Wei Tang; Cheryl J Smith; Olusegun O Onabajo; Adeola Obajemu; Tiffany H Dorsey; Symone V Jordan; Obadi M Obadi; Bríd M Ryan; Ludmila Prokunina-Olsson; Christopher A Loffredo; Stefan Ambs
Journal:  Commun Biol       Date:  2018-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.